Dr Explains Exactly How TB500 Should Work

22 Mar 2026 · 1 min

Watch on YouTube

1:14

In this segment, the speaker explains that TB-500 is derived from the naturally occurring protein thymosin beta-4, which was first identified in the 1980s during research on immune responses and wound healing. Researchers observed that thymosin beta-4 was released by immune cells at sites of tissue injury and appeared to facilitate not only local healing but also the migration of repair cells throughout the body. The active portion of thymosin beta-4 was later isolated as the smaller peptide TB-500. The speaker details the proposed mechanism: TB-500 binds to actin, the cellular cytoskeletal component that governs cell shape and movement, thereby enhancing actin dynamics and improving the efficiency with which repair cells travel to damaged tissue.

Chapters

TB500 comes from a naturally occurring protein in the body called thymosin beta-4. It was discovered while researchers were investigating the immune system and wound healing. Back in the '80s, scientists noticed that certain immune cells released a protein that showed up every time tissue injury occurred, whether it was skin wounds, muscle damage, inflammation, that protein was present, and that protein is thymosin beta-4. And what caught the attention of the research was that it didn't just help tissue heal locally. It seemed to help repair cells move throughout the body toward areas of injury. Later on, scientists identified the active region responsible for many of these effects, and that smaller fragment became what we now call TB-500. And if you need to be nerdy with it, the way TB-500 does this is it binds to actin. Actin is basically the internal skeleton of a cell. It's what allows cells to change shape and physically move through tissue. And since healing requires repair cells to migrate into injured areas, anything that improves actin dynamics can improve how efficiently those cells reach damage.